title: Reply to D. Vordermark and T. Pelz and R. Mazzola et al.
authors.affiliation: The Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Frederika A
authors.initials: FA
authors.lastname: van Nimwegen
authors.affiliation: University of Oxford, Oxford, United Kingdom.
authors.forename: David J
authors.initials: DJ
authors.lastname: Cutter
authors.affiliation: The Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Michael
authors.initials: M
authors.lastname: Schaapveld
authors.affiliation: University of Oxford, Oxford, United Kingdom.
authors.forename: Sarah C
authors.initials: SC
authors.lastname: Darby
authors.affiliation: The Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Berthe M P
authors.initials: BM
authors.lastname: Aleman
authors.affiliation: The Netherlands Cancer Institute, Amsterdam, Netherlands f.v.leewen@nki.nl.
authors.forename: Flora E
authors.initials: FE
authors.lastname: van Leeuwen
mesh_terms: D003327:Coronary Disease / Q000209:etiology*; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D011832:Radiation Injuries